ABOS · Acumen Pharmaceuticals, Inc. · Exempt Offerings
$0.19
-0.01 (-3.52%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Oct 26, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current operating plan, we believe there is substantial doubt about our ability to continue as a going concern for at least 12 months following the date of issuance of our unaudited condensed financial statements included in this Quarterly Report on Form 10-Q.”View the 10-Q filed Oct 26, 2026
Market Cap
$13.49M
Shares
72.33M
Volume · Nov 20
2.71M
Avg daily vol (3M)
2.7M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1576885
CUSIP
00509G209
13F (30d)
103 filings
89 filers
Visit website
Investor relations